Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

NCT02648347 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1751

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Non-Dialysis-Dependent Chronic Kidney Disease

Interventions

DRUG: Vadadustat
DRUG: Darbepoetin alfa

Sponsor

Akebia Therapeutics